Tag: osteoarthritis market report

  • Critical Market Drivers Shaping the Outlook for Osteoarthritis Market from 2025-2034: Rising Obesity-Related Disorders Fuel Growth In The Osteoarthritis Market

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Osteoarthritis Market Growth Performance Trended Historically, And What Lies Ahead?

    Over recent years, the market size for osteoarthritis has seen significant expansion. The market value is predicted to rise from $6.87 billion in 2024 to $7.49 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.1%. The previous growth periods owe their progress to factors like the rising elderly population, increasing obesity epidemic, advancements in imaging techniques, and improved pain management.

    The market size for osteoarthritis is predicted to witness robust growth in the coming years. The market is expected to expand to an estimation of$10.74 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.4%. The reasons for growth during the forecasted timeframe include the use of non-pharmacological methods, disease-altering osteoarthritis drugs (dmoads), personalized treatment, telehealth services, and remote patient monitoring. Other trending factors over the forecast period include the advent of regenerative therapies, the use of wearable medical devices, the incorporation of artificial intelligence in diagnostics, and digital health solutions.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

    What Are the Core Growth Drivers Propelling the Osteoarthritis Market Forward?

    The surge in obesity-related diseases is anticipated to fuel the expansion of the osteoarthritis market. Obesity-related conditions encompass numerous health complications resulting from an excess of body fat. It’s generally caused by taking in more calories than your body can burn during physical activity and workouts, or from excessive consumption of processed foods, fast foods, and alcohol. Obesity can exacerbate osteoarthritis by placing additional strain on joints, causing inflammation, and disrupting hormone regulation, which ultimately increases the burden on the joints. For example, the World Obesity Atlas 2022, produced by the UK’s non-profit World Obesity Federation, predicts that by 2030, 1 billion people globally (including 1 in 7 men and 1 in 5 women) will be obese. By 2035, this number is estimated to increase to 4 billion people, equating to 51% of the global population, either overweight or obese. Consequently, the surge in obesity-related diseases is propelling the osteoarthritis market’s growth.

    What Segment Types Define the Osteoarthritis Market Structure?

    The osteoarthritismarket covered in this report is segmented –

    1) By Treatment: Medication; Surgery; Therapy

    2) By Diagnosis: Imaging; Joint Fluid Analysis

    3) By Route Of Administration: Parenteral Route; Topical Route; Oral Route

    4) By Disease Type: Knee Osteoarthritis; Spine Osteoarthritis; Foot And Ankle Osteoarthritis; Shoulder Osteoarthritis; Hand Osteoarthritis

    5) By End-User: Hospitals; Medical Institutes

    Subsegments:

    1) By Medication: Pain Relievers; Corticosteroids; Hyaluronic Acid Injections; Disease-Modifying Osteoarthritis Drugs (DMOADs)

    2) By Surgery: Joint Replacement Surgery; Arthroscopy; Osteotomy; Joint Fusion

    3) By Therapy: Physical Therapy; Occupational Therapy; Weight Management Programs; Assistive Devices

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Osteoarthritis Market?

    North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Which Emerging Trends that Are Influencing theOsteoarthritis Industry Evolution?

    Leading companies in the osteoarthritis market are leveraging strategic partnerships to improve their technological capabilities and broaden their market presence. This kind of partnership usually involves a cooperative relationship among two or more companies, pooling their resources, knowledge, and efforts to attain shared goals. For instance, in July 2024, LG Chem, a pharmaceutical firm based in South Korea, penetrated the Chinese market by partnering with Yifan Pharmaceutical Co., Ltd., a pharma research and manufacturing company based in China. Their collective effort led to the introduction of the Synovian injection for osteoarthritis, which mirrors the therapeutic effects of traditional multi-injection formulations with just a single administration. Synovian comes with unique characteristics like its incredibly high molecular weight (10 million Dalton) hyaluronic acid that boosts viscoelasticity and joint operation, and its proven ability to dramatically lessen knee pain as per the results from the clinical phase 3 trial. These developments place Synovian on the map as a promising solution for people looking for efficient relief from osteoarthritis symptoms.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

    What Is the Definition of the Osteoarthritis Market?

    Osteoarthritis is a form of arthritis that solely affects the joints, typically the hands, knees, hips, neck and lower back. It develops when the cartilage that covers and shields the ends of the bones gradually erodes. Osteoarthritis treatment aims to reduce pain, improve joint function and slow down the progression of the disease.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13022

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Osteoarthritis Market Outlook 2025 – Insights for Executive and Strategic Planning

    Osteoarthritis Market Outlook 2025 – Insights for Executive and Strategic Planning

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    #How Has the Osteoarthritis Market Grown from 2024 to 2025?#_x000D_

    In the past few years, the market for osteoarthritis has seen robust growth. It is expected to expand from $6.87 billion in 2024 to $7.53 billion in 2025, marking a compound annual growth rate (CAGR) of 9.6%. Several factors have contributed to this growth during the historic period, including an aging population, the obesity crisis, and advancements in imaging and pain management._x000D_

    _x000D_

    #What Growth Rate Is Anticipated for the Osteoarthritis Market in the Coming Years?#_x000D_

    In the coming years, the osteoarthritis market is projected to experience significant growth, rising to a value of $10.64 billion in 2029, with a compound annual growth rate (CAGR) of 9.0%. Non-pharmacological methods, disease-altering osteoarthritis drugs (dmoads), personalized treatments, telehealth, and distant tracking can all contribute to this growth throughout the projected period. Regenerative treatments, wearable technology, the use of artificial intelligence for diagnosis, and digital health resources are among the key trends predicted for this period._x000D_

    _x000D_

    #Download The Free Sample Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp_x000D_

    _x000D_

    #Who Are the Leading Companies in the Osteoarthritis Market?#_x000D_

    Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc._x000D_

    _x000D_

    #What Are the Key Drivers of the Osteoarthritis Market?#_x000D_

    The growth of the osteoarthritis market is predicted to be fuelled by the rise in obesity-related disorders. These health issues stem from carrying excess body fat, which can be the result of consuming more calories than the body uses, the intake of high volumes of processed food, and excessive alcohol consumption. Obesity increases the chance of osteoarthritis as it places additional pressure on the joints, triggers inflammation, and interferes with hormone regulation, thereby adding more load on the joints. For example, the World Obesity Atlas 2022, presented by the UK-based World Obesity Federation, states that by 2030, obesity will affect 1 billion individuals across the globe, including 1 out of every 7 men and 1 in every 5 women. It is also projected that by 2035, this will escalate to 4 billion people, representing 51% of the global population, who will be overweight or obese. Thus, the growing prevalence of obesity-related disorders is contributing to the expansion of the osteoarthritis market.

    Driver for Osteoarthritis Market Growth: Boost from Extensive Use of Painkillers

    _x000D_

     

    _x000D_

    #Request For A Customized Report:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp_x000D_

    _x000D_

    #What Are the Key Market Segments in the Osteoarthritis Industry?#_x000D_

    The osteoarthritis market covered in this report is segmented –_x000D_

    _x000D_

    1) By Treatment: Medication, Surgery, Therapy_x000D_

    2) By Diagnosis: Imaging, Joint Fluid Analysis_x000D_

    3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route_x000D_

    4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis_x000D_

    5) By End-User: Hospitals, Medical Institutes_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)_x000D_

    2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion_x000D_

    3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices_x000D_

    _x000D_

    #What Are the Latest Trends in the Osteoarthritis Market?#_x000D_

    Leading firms in the osteoarthritis sector are employing strategic alliances as a means to improve technology fusion and broaden their market influence. Strategic partnership is often used to describe a cooperative interaction between two or more firms, where they merge their resources, knowledge, and energy to attain mutual targets or aims. For example, in July 2024, South Korea’s LG Chem moved into the Chinese market through a collaboration with Yifan Pharmaceutical Co., Ltd., a China-based pharmaceutical research and manufacture firm. This partnership allowed them to introduce Synovian injection for osteoarthritis which carries similar therapeutic capacities as conventional multi-injection formulations, but requires only a single dose. Synovian’s distinctive attributes include its high molecular weight (10 million Dalton) hyaluronic acid, which improves viscoelasticity and joint functionality, and its proven ability to significantly alleviate knee pain based on phase 3 clinical trial outcomes. These developments position Synovian as a viable choice for patients seeking easy relief from osteoarthritis symptoms._x000D_

    _x000D_

    #Access The Full Report Here:#_x000D_

    https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report_x000D_

    _x000D_

    #What Are the Key Regional Markets in the Osteoarthritis Industry?#_x000D_

    North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

    _x000D_

    #Purchase The Full Report Today:#_x000D_

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13022_x000D_

    _x000D_

    #This Report Delivers Insight On: #_x000D_

    1. How big is the osteoarthritis market, and how is it changing globally?_x000D_

    2. Who are the major companies in the osteoarthritis market, and how are they performing?_x000D_

    3. What are the key opportunities and risks in the osteoarthritis market right now?_x000D_

    4. Which products or customer segments are growing the most in the osteoarthritis market?_x000D_

    5. What factors are helping or slowing down the growth of the osteoarthritis market?_x000D_

    _x000D_

    #About The Business Research Company:#_x000D_

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 310-496-7795_x000D_

    Asia +44 2071930708_x000D_

    Europe +44 7882 955267_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Osteoarthritis Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

    Osteoarthritis Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the osteoarthritis market?

    The osteoarthritis market has seen strong growth, with projections increasing from $6.87 billion in 2024 to $7.53 billion in 2025, at a 9.6% CAGR. The historical growth can be attributed to an aging population, the obesity epidemic, advancements in imaging technology, and innovations in pain management.

    What will be the osteoarthritis market size in the future?

    The osteoarthritis market is expected to see strong growth, reaching $10.64 billion by 2029 with a CAGR of 9.0%. Growth drivers include non-pharmacological treatment approaches, disease-modifying osteoarthritis drugs (DMOADs), personalized medicine, and telehealth expansion. Key trends include the development of regenerative therapies, wearable devices, AI-assisted diagnosis, and digital health tools.

    Get your osteoarthritis market report here!

    https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

    What main drivers are fueling expansion in the osteoarthritis market?

    The increasing incidence of lung cancer is projected to fuel the growth of the osimertinib drug market. Lung cancer originates in the lung tissues and is primarily treated with osimertinib, which inhibits the activity of proteins involved in cancer cell growth. According to the American Cancer Society, approximately 236,740 lung cancer cases were diagnosed in the US in 2022, rising to 238,340 in 2023. This growing number of lung cancer cases is supporting the expansion of the osimertinib drug market.

    What key areas define the segmentation of the global osteoarthritis market?

    The osteoarthritis market covered in this report is segmented –

    1) By Treatment: Medication, Surgery, Therapy

    2) By Diagnosis: Imaging, Joint Fluid Analysis

    3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

    4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis

    5) By End-User: Hospitals, Medical Institutes

    Subsegments:

    1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)

    2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion

    3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

    Who are the dominant players expanding their reach in the osteoarthritis market?

    Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

    How are evolving market trends shaping osteoarthritis Strategies?

    Key corporations in the osteoarthritis sector are utilizing strategic partnerships as a method to augment technological integration and widen their market influence. This strategy pertains to a cooperative relationship shared among multiple organizations aiming to pool their resources, skills, and endeavors to fulfill shared aims or goals. As an example, the South Korean pharmaceutical firm LG Chem broke into the Chinese market in July 2024 by partnering with Yifan Pharmaceutical Co., Ltd., a pharmaceutical research and production company based in China. Their collaboration led to the introduction of Synovian injection for treating osteoarthritis, offering similar therapeutic benefits to conventional multi-injection formulas but requiring only a single administration. Synovian has some unique attributes, such as its high molecular weight (10 million Dalton) hyaluronic acid, contributing to enhance viscoelasticity and joint function, along with the proven ability to significantly alleviate knee pain as per the outcomes of clinical phase 3 trials. This development establishes Synovian as an effective treatment option for patients looking for easy mitigation from the symptoms of osteoarthritis.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13022

    Which regions are emerging as leaders in the osteoarthritis market?

    North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Bone And Joint Health Supplements Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/bone-and-joint-health-supplements-global-market-report

    Companion Animal Arthritis Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

    Psoriatic Arthritis Treatment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • In-Depth Insights into the Osteoarthritis Market: Growth, Trends, and Opportunities for 2025-2034

    In-Depth Insights into the Osteoarthritis Market: Growth, Trends, and Opportunities for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Are the Projected Expansion Rates of the Osteoarthritis Market for the Next Decade?

    In recent times, there has been a robust expansion in the osteoarthritis market size. The projection is an increase from $6.87 billion in 2024 to $7.53 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. The growth during the historical period is mainly due to factors like an aging population, increasing obesity rates, advancement in imaging techniques, and pain management.

    The market scale for osteoarthritis is projected to expand significantly in the upcoming years. It is estimated to reach $10.64 billion in 2029, with a compound annual growth rate (CAGR) of 9.0%. Non-pharmacological strategies, disease-altering osteoarthritis medications (dmoads), customized healthcare, telemedicine, and remote supervision contribute to the anticipated growth in this forecast period. Key trends during this period will involve regenerative treatments, wearable technology, application of artificial intelligence in diagnosis, and digital health instruments.

    Which Drivers Are Expected to Have the Greatest Impact on the Osteoarthritis Market’s Growth?

    The rise in disorders related to obesity is predicted to fuel the expansion of the osteoarthritis market. Obesity-related issues encompass various health problems that can stem from excessive body fat accumulation, which is a result of consuming more calories than the body is able to burn through physical activity and exercise, indulging in excessive processed or fast food and consuming excessive alcohol. Obesity can lead to osteoarthritis by putting undue stress on joints, causing inflammation, and altering hormonal balances, which increases the load-bearing strain on the joints. The World Obesity Atlas 2022, released by the World Obesity Federation, a non-profit organization from the UK, projects that by 2030, around 1 billion people globally, including 1 out of 7 men and 1 out of 5 women, will be suffering from obesity. By 2035, this number is expected to rise to 4 billion people or 51% of the world’s population, who will be either overweight or obese. Hence, the rising rates of obesity-related disorders are a driving factor for the growth of the osteoarthritis market. One of the major factors influencing the growth of the osteoarthritis market is the extensive usage of painkillers. Painkillers, which are drugs or substances utilized to provide pain relief, work by reducing pain perception, which can help ease the discomfort associated with different conditions or damages. The comprehensive use of painkillers in managing osteoarthritis, spurred by the necessity for effective pain management, can significantly affect the osteoarthritis market. This can result in heightened demand, affect treatment protocols, incite research and development activities, and elevate awareness about the disease. A study conducted in June 2022 by the Consumer Healthcare Products Association, a trade association in the US, revealed that nearly 80% of participants reported that their consumption of over-the-counter pain relievers has either stayed the same (49%) or increased (30%) over the past two years. Hence, the broad usage of painkillers is a key driving force for the expansion of the osteoarthritis market.

    Get Your Free Sample of the Global Osteoarthritis Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

    Which Companies Are Redefining the Future of the Osteoarthritis Market?

    Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

    What Trends Are Poised to Drive the Future Success of the Osteoarthritis Market?

    Key corporations in the osteoarthritis sector are utilizing strategic partnerships as a method to augment technological integration and widen their market influence. This strategy pertains to a cooperative relationship shared among multiple organizations aiming to pool their resources, skills, and endeavors to fulfill shared aims or goals. As an example, the South Korean pharmaceutical firm LG Chem broke into the Chinese market in July 2024 by partnering with Yifan Pharmaceutical Co., Ltd., a pharmaceutical research and production company based in China. Their collaboration led to the introduction of Synovian injection for treating osteoarthritis, offering similar therapeutic benefits to conventional multi-injection formulas but requiring only a single administration. Synovian has some unique attributes, such as its high molecular weight (10 million Dalton) hyaluronic acid, contributing to enhance viscoelasticity and joint function, along with the proven ability to significantly alleviate knee pain as per the outcomes of clinical phase 3 trials. This development establishes Synovian as an effective treatment option for patients looking for easy mitigation from the symptoms of osteoarthritis.

    Get Instant Access to the Global Osteoarthritis Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

    Which Primary Segments of the Osteoarthritis Market Are Driving Growth and Industry Transformations?

    The osteoarthritis market covered in this report is segmented –

    1) By Treatment: Medication, Surgery, Therapy

    2) By Diagnosis: Imaging, Joint Fluid Analysis

    3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

    4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis

    5) By End-User: Hospitals, Medical Institutes

    Subsegments:

    1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)

    2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion

    3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

    What Are the Leading Regions in the Osteoarthritis Market Expansion?

    North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    How Can We Define the Osteoarthritis Market and Its Key Components?

    Osteoarthritis is a form of arthritis that solely affects the joints, typically the hands, knees, hips, neck and lower back. It develops when the cartilage that covers and shields the ends of the bones gradually erodes. Osteoarthritis treatment aims to reduce pain, improve joint function and slow down the progression of the disease.

    Browse Through More Similar Reports By The Business Research Company:

    Bone And Joint Health Supplements Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/bone-and-joint-health-supplements-global-market-report

    Companion Animal Arthritis Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

    Psoriatic Arthritis Treatment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • In-Depth 2024 Osteoarthritis Market Analysis: Growth, Share, and Emerging Trends

    In-Depth 2024 Osteoarthritis Market Analysis: Growth, Share, and Emerging Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Osteoarthritis Market from 2024 to 2033?

    The osteoarthritis market size has seen rapid growth, expected to grow from $6.24 billion in 2023 to $6.87 billion in 2024, with a CAGR of 10.1%. The increase can be attributed to the aging population, the obesity epidemic, advances in imaging, and pain management.

    The osteoarthritis market is set to grow robustly, reaching $9.69 billion in 2028 at a CAGR of 9.0%. This increase is attributed to the rise of non-pharmacological approaches, disease-modifying osteoarthritis drugs (DMOADs), personalized medicine, telehealth, and remote monitoring. Notable trends include regenerative therapies, wearable devices, AI in diagnosis, and digital health tools.

    Claim Your Free Sample of the Global Osteoarthritis Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

    Increasing obesity-related disorders are anticipated to propel growth in the osteoarthritis market. Obesity places stress on joints, triggers inflammation, and alters hormones, all contributing to osteoarthritis. The World Obesity Federation reported in 2022 that 1 billion people worldwide, including 1 in 7 men and 1 in 5 women, are projected to live with obesity by 2030, with overweight or obesity affecting 51% of the global population by 2035. This trend is expected to drive growth in the osteoarthritis market.

    1) By Treatment: Medication, Surgery, Therapy

    2) By Diagnosis: Imaging, Joint Fluid Analysis

    3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

    4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis

    5) By End-User: Hospitals, Medical Institutes

    Companies in the osteoarthritis market are developing new products like small molecule inhibitors, hyaluronic acid intra-articular injections, and single injection viscosupplements to maintain market standing. For instance, in August 2021, Seikagaku Corporation introduced HyLink, a single-injection viscosupplement for knee osteoarthritis. This product, made with Seikagaku’s exclusive crosslinking technique, aims to provide long-lasting relief from symptoms with just a 3ml dose, significantly improving knee lubrication and reducing pain.

    Order Now for Fast Delivery of Your Osteoarthritis Market Report!

    https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

    North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Osteoarthritis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the osteoarthritis market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Osteoarthritis Market Include

    1. Osteoarthritis Market Executive Summary

    2. Osteoarthritis Market Segments

    3. Osteoarthritis Market Size And Template Market Growth Rate

    4. Key Osteoarthritis Market Trends

    5. Major Osteoarthritis Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Osteoarthritis Market

    26. Top Osteoarthritis Companies

    27. Osteoarthritis Market Opportunities And Strategies

    28. Osteoarthritis Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Arthritis Monoclonal Antibodies Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report

    Psoriatic Arthritis Treatment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report

    Companion Animal Arthritis Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: